View More Recent Stories

Apr 14, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Tango Therapeutics Inc. (TNGX)
Jan 2, 2025 12:51PM Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'
Nov 6, 2024 07:15AM Tango Therapeutics, Inc. (TNGX) Tops Q3 EPS by 10c
Nov 6, 2024 07:11AM Tango Therapeutics, Inc. (TNGX) Tops Q3 EPS by 10c
Nov 6, 2024 07:02AM Tango Therapeutics, Inc (TNGX) Reports Positive TNG462 Clinical Data, Provides Update on PRMT5 Development Program
Oct 28, 2024 07:29AM H.C. Wainwright Reiterates Buy Rating on Tango Therapeutics Inc. (TNGX)
Oct 15, 2024 05:59AM Leerink Partners Reiterates Outperform Rating on Tango Therapeutics Inc. (TNGX)
Sep 17, 2024 07:20AM Piper Sandler Reiterates Overweight Rating on Tango Therapeutics Inc. (TNGX)
Sep 10, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on Tango Therapeutics Inc. (TNGX)
Sep 9, 2024 07:37AM Piper Sandler Reiterates Overweight Rating on Tango Therapeutics Inc. (TNGX)
Jul 17, 2024 02:21AM Jefferies Starts Tango Therapeutics Inc. (TNGX) at Buy
View More Recent Stories